$VXRT Some interesting points in this article dated 8th July from nejm.org/action/cookieAbsent "T-cell immunity is important in the control of SARS-CoV-22 and may be critical for potential cross-reactive protection against variants. SARS-CoV-2 messenger RNA (mRNA) vaccines generate weaker T-cell responses than other vaccine platforms." "we would encourage consideration of a vaccine boost from a T-cell–skewed vaccine after mRNA vaccination to boost T-cell responses and potentially to reduce the chance of breakthrough infection through the generation of cross-protective T-cell immunity." " GO VAXART! THE HOLY GRAIL!